AEK-9202412-2/10002/1

Abbvie Biotechnology Gmbh — FEI 3011277200

Refusal Details

Date
January 18, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58SCY14 ADALIMUMAB
Charges
75